Healthcare >> CEO Interviews >> May 3, 2004

Dominic Behan – Arena Pharmaceuticals Inc (arna)

DOMINIC BEHAN is Vice President of Research at Arena Pharmaceuticals, Inc. He received his PhD in 1990 in Neuroendocrinology and Biochemistry from Reading University, England. From 1990 to 1993, Dr. Behan was engaged in research at the Salk Institute. His early work focused on the isolation and characterization of a protein that modulates neurostransmitter systems controlling stress. In 1993, Dr. Behan joined Neurocrine Biosciences during its startup phase as a member of the early core scientific team and directed various research programs at Neurocrine from 1993-1997. Dr. Behan is a co-Founder of Arena and has served as Vice President, Research since April 1997 and as a Director since April 2000. At Arena, his scientific focus has been on the discovery of small molecule modulators to an important class of cell surface proteins, GPCRs, across multiple therapeutic areas. Profile
TWST: We'd like to begin with a brief historical sketch of Arena

Pharmaceuticals and a picture of the things you're doing at the present

time.

Dr. Behan: Arena was founded by myself, Derek